Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Spine-Tech

This article was originally published in The Gray Sheet

Executive Summary

Spine-Tech: Firm plans controlled worldwide market launch in the fourth quarter of 1997 of its BAK/Proximity implant for use in spinal fusion procedures to treat symptomatic degenerative disc disease following recent marketing clearance from FDA, the firm states. The device, which is intended for use in patients with a small anatomy, differs from the firm's flagship BAK implant in that it features "greater porosity," concave sides, and allows for closer placement between the vertebrae of two implants, one BAK and one BAK/Proximity...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009023

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel